Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted July 6, 2021
CBD Products Were Promoted to Treat Cancer and Alzheimer's Without Proof, Says FTC
On July 6, 2021, the Federal Trade Commission (FTC) announced that it has approved a final administrative consent orders against Kushly Industries LLC and the company's owner, Cody Alt, for allegedly making unsupported health claims about its CBD products.
According to the FTC's complaint, the company made false claims that Kushly CBD products could treat or cure serious conditions such as cancer, multiple sclerosis, Parkinson's disease, and Alzheimer's disease, as well as hypertension, psoriasis and acne.
(See ConsumerLab's answers to the questions Do supplements help with Parkinson's disease treatment or prevention? and Do any supplements reduce multiple sclerosis symptoms or relapse?)
The final order requires Kushly to pay $30,583.14 (the amount consumers paid the company for the falsely promoted products), and bans the company from making unsubstantiated claims about its products.
Consumers are encouraged to report scams, fraud, and bad business practices at ReportFraud.ftc.gov.
See ConsumerLab's Review of CBD & Hemp Extract Supplements, Lotions, and Balms for tests of related products.
For more information, use the link below.
FTC Approves Final Administrative Consent Order against Kushly Industries LLC and its Owner for Making Unsupported Health Claims for CBD Products
See related recalls and warnings:
FTC Takes Further Action Against Deceptive CBD Claims
FTC Crackdown on Six Deceptive CBD Products
FDA Warns Sellers of Unapproved COVID-19 Tests, CBD Products
Seller of CBD and NAC Warned for Coronavirus Claims
51 CBD Products Recalled Due to Lead Contamination
Seller of CBD Tinctures and "Immune Boost Packs" Warned for Coronavirus Claims